Recent Articles from Business Wire

Xfinity has once again been recognized as a broadband leader in Opensignal’s latest U.S. Fixed Broadband Experience Report, earning more top rankings than any other major provider in the country. Xfinity ranked #1 nationally among the five largest U.S. internet providers in three key categories: Consistent Quality, Download Speed, and Video Experience. Additionally, in head-to-head comparisons within its footprint, Xfinity won for Most Reliable WiFi, underscoring the strength and reliability of Xfinity’s network both nationally and locally.

AM Best will speak, sponsor and exhibit at the Philippine Insurance Summit on Wednesday, 3 June 2026 in Makati City, Philippines at the Fairmont Hotel.

Massive Bio, a global precision oncology company, today announced a new partnership with TOUCH, The Black Breast Cancer Alliance (TOUCH BBCA), a breast cancer patient advocacy organization, and Navigating Trials, a clinical trial navigation platform serving patients across all cancer types. Through this collaboration, Massive Bio's AI-powered trial matching will be made available directly within both organizations' digital platforms, giving their patient communities a seamless, no-cost pathway to personalized clinical trial options.

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Tokio Marine Canada Ltd. (TMC) (Toronto, ON). The outlook of these Credit Ratings (ratings) is stable.

Kalshi, the next-generation financial market, today announced the launch of perpetual futures contracts, making Kalshi the first company in American history to offer perpetuals. U.S. investors will soon be able to access crypto perpetual futures on Kalshi's platform, fully regulated by the Commodity Futures Trading Commission (CFTC).

Beren Therapeutics P.B.C., the parent company of Mandos LLC and a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, today announced that the company will present six posters at the 2026 Michael, Marcia, and Christa Parseghian Scientific Conference for Niemann-Pick Type C Research, sponsored by the family of former Notre Dame head football coach Ara Parseghian, taking place May 30 through June 2 in Tucson, Arizona. The posters present clinical and preclinical data on adrabetadex, an investigational cyclodextrin-based therapy under review by the U.S. Food and Drug Administration (FDA) for infantile-onset Niemann-Pick disease, type C (I-NPC). Beren’s Chief Executive Officer Jason Camm will also participate in a fireside chat at the conference with APMRF director Sean Kassen on Sunday, May 31 at 4 p.m. MST.

DigitalOcean Holdings, Inc. (NYSE: DOCN), the AI-Native Cloud, purpose-built for inference and agentic workloads, today announced that Chief Financial Officer Matt Steinfort and SVP of Corporate Development and Investor Relations Radu Patrichi will participate in a fireside chat at the Bank of America Global Technology Conference on Wednesday June, 3 at 2:00 p.m (PT) / 5:00 p.m (ET).

Marquee Brands, the U.S.-based company specializing in the acquisition, management, and development of a diversified portfolio of global consumer lifestyle brands, together with The Level Group (TLG), acting as principal operating partner, have entered into a binding agreement to acquire control of the Roberto Cavalli brand as part of a complex strategic reorganization of the group. The transaction was concluded with DAMAC Group, the Dubai-based multinational conglomerate founded by entrepreneur Hussain Sajwani and active in the management of luxury assets, which has agreed to transfer the majority of the Italian brand.

Leeward Renewable Energy Operations, LLC (“LREO”) today announced that it has posted key operating and financial results for the first quarter of 2026 to its secure investor relations site.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Aldeyra Therapeutics, Inc. (“Aldeyra” or “the Company”) (NASDAQ: ALDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pinterest, Inc. (“Pinterest” or “the Company”) (NYSE: PINS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

AM Best has assigned a Financial Strength Rating of A++ (Superior) and a Long-Term Issuer Credit Rating of “aa+” (Superior) to Park Avenue Life Insurance Company (PALIC) (Wilmington, DE). The outlook assigned to these Credit Ratings (ratings) is stable.

Tanium, a leader in Autonomous IT, today announced a partnership with Censys, the authority for Internet intelligence, to deliver a unified approach to exposure management that enables organizations to continuously identify, prioritize and remediate risk across both internal and external attack surfaces.

AM Best has been named a Telly Award bronze winner for its “Our Vision” video. “Our Vision” highlights AM Best’s goal to be the world’s most recognized, accepted and respected full-service credit rating agency, news publisher and data analytics provider specializing in the insurance industry.

Curebound, a cancer research accelerator, today announced that its 2026 Concert for Cures, headlined by global music icon P!NK, raised $8.25 million, bringing the total raised across the four-year history of the concert series to more than $28 million for cancer research. The May 15 concert at Petco Park drew 25,000 fans, including thousands of cancer survivors, 1,500 who were invited to attend by the Manchester Family Foundation.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Pinterest, Inc. (“Pinterest” or the “Company”) (NYSE: PINS) and reminds investors of the May 29, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX) and reminds investors of the May 29, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the latest results from its mission to build Multimodal Foundation Models at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Tempus has been building novel biological foundation models and agentic workflows by leveraging its more than 500 petabytes of rich, molecularly grounded data—more than 45 million total de-identified patient journeys, 1.5 million with sequenced data, and over 400,000 records in cancer with full genomic, transcriptomic, imaging, and clinical data. These efforts transform this data into unified patient representations, unlocking actionable insights to speed precision medicine efforts in both the clinic and drug development.

DevvStream Corp. (NASDAQ: DEVS) ("DevvStream" or the "Company"), XCF Global, Inc. (NASDAQ: SAFX) ("XCF"), and Southern Energy Renewables Inc. ("Southern") (together, the "Parties") wish to clarify recent media coverage that mischaracterized a current report on Form 8-K filed by DevvStream with the U.S. Securities and Exchange Commission (the "SEC") on May 18, 2026 (the "8-K").

Equity Data Science (EDS), a leading provider of Investment Process Management (IPM) solutions for hedge funds and asset managers, today announced the appointment of Sebastian Lonza, CFA, CAIA as Chief Revenue Officer (CRO). Lonza joins EDS with deep expertise across portfolio analytics, risk management, and enterprise technology, bringing over a decade of experience helping institutional investors modernize their investment workflows.

Ambience Healthcare, the leading intelligence platform for clinical documentation and revenue integrity, today announced a significant expansion of chart-aware intelligence across its inpatient platform. Ambience previously introduced chart awareness, enabling AI to read and reason over a patient's full record rather than the conversation from a single encounter.

The partners who earned 8x8's top channel honors this year did it the same way: new customers, real growth, and measurable results. 8x8, Inc. (NASDAQ: EGHT), a leading global business communications platform provider, named its 2026 Partner Award winners across nine categories spanning contact center, unified communications, CPaaS, distribution, and technology partnerships. The awards recognize partners who drove the strongest revenue growth, net-new customer acquisition, and year-over-year performance during the fiscal year ended March 31, 2026.

Chime® (Nasdaq: CHYM), The #1 Most Loved Banking app1, and Invest America kicked off the Compound Combine yesterday in Jersey City, N.J. The event is the first in a new series of financial education community events designed to help families learn how wealth builds over time.

Newegg (Newegg Commerce, Inc., NASDAQ: NEGG), a global leader in computer and technology products, today announced its participation at the 2026 Taipei International Computer Show (COMPUTEX 2026), taking place June 2–5. Marking Newegg's 25th anniversary year, the showcase is the company's largest-ever Computex footprint, anchored by an expanded Gamer Zone, the debut of Newegg Simulator Builder, and an international PC Builder Championship featuring leading creators from four countries.

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise.

XCENA, providing memory-centric computing solutions for AI infrastructure, today announced it has closed $135 million (KRW 202 billion) in a Series B financing round. XCENA will use the funding to accelerate the company’s global expansion, scale customer deployments, and advance its next-generation computational memory solution. Total fundraising now stands at $185 million with a current valuation of $570 million.

Accelerant (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced Jeff Radke, Chairman and Chief Executive Officer, will be presenting at the William Blair Growth Stock Conference on Wednesday, June 3, 2026 at 10:20 am Eastern Time.

Artificial intelligence is turning collaboration software into an orchestration layer that automatically translates human interactions into enterprise decisions and actions, according to new research from global AI-centered technology research and advisory firm Information Services Group (ISG) (Nasdaq: III).

Chevron Corporation (NYSE: CVX) today announced the appointment of Scott A. Keller as general counsel.

Akkio, the AI infrastructure that powers agentic workflows across media companies, today announced the appointment of Christian Juhl to its board of directors. Juhl, who served as global CEO of GroupM, brings decades of executive leadership across data-driven media, agency transformation, and technology-forward growth to Akkio's board.

Law Offices of Howard G. Smith announces an investigation on behalf of Photronics, Inc. (“Photronics” or the “Company”) (NASDAQ: PLAB) investors concerning the Company’s possible violations of federal securities laws.

The Pershing Square Foundation (the “Foundation”) today announced $6 million in funding to support eight pioneering scientists advancing innovative ovarian cancer research across the United States.

Elevate Quantum, today in partnership with Front Range Community College (FRCC) and University of Colorado Denver, today announced the launch of its Vacuum and Cryogenic Technician Training Program, a first-of-its-kind, specialization-focused workforce initiative housed within its commercialization lab at Quantum Commons. Elevating Quantum Upskilling through Industry Proficiencies (EQUIP) is a program designed to produce technician-ready talent capable of operating, troubleshooting, and maintaining complex cryogenic and quantum systems from day one on the job.

Tompkins Community Bank (Tompkins) is pleased to announce the appointment of John Huhtala as president of its Central New York market. In this role, Huhtala will lead the company’s market presence, with a focus on strengthening client relationships, expanding business development efforts, deepening community engagement and supporting collaboration across the organization.

QuantHealth, the category leader in AI-driven clinical trial simulation, today announced the launch of its predictive competitive intelligence solution, an unprecedented capability designed to help life sciences organizations optimize not only for clinical trial success, but for future market leadership.

Appriss Retail, the total loss platform for omnichannel retailers, today announced the release of Sidekick, a workflow intelligence layer for returns, shrink, and incidents, natively built into the Appriss Retail platform. Unlike generic conversational chatbots that surface information, Sidekick acts on it by surfacing anomalies and trends, opening investigations, assigning work items, tracking outcomes like returns prevented, and guiding users through plain-language conversations.

Zef Scientific, Inc. (ZefSci), the leading North America independent service provider of multivendor LCMS systems, today announced a partnership with Boston based Peak Life Science Advisors, LLC with industry expert Rick Carberry.

Southern Glazer's Wine & Spirits (Southern Glazer's)—the world’s preeminent distributor of beverage alcohol—today announced the successful closing of its acquisition of substantially all of the assets of Clare Rose Inc. (Clare Rose). Effective immediately, the business will operate under the name Southern Glazer’s Beverage Company of New York, servicing Nassau and Suffolk counties in Long Island, New York.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of enGene Therapeutics Inc. (“enGene” or “the Company”) (NASDAQ: ENGN) for violations of the securities laws.

Today, the company formerly known as CallBotics rebranded as Orvera AI. The CAIP category serving enterprise contact centers has moved past the vocabulary of "bots”. Industry research projects that by the end of 2027, virtual assistants and conversational AI agents will automate approximately 70 percent of customer service and support interactions within enterprises that have deployed conversational AI solutions, up from approximately 50 percent in 2025. Enterprise buying committees are evaluating CAI platforms through a single RFP that spans voice, chat, email, and live AI assistance for human representatives.

Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTC: MVMDF) is pleased to report on the advancement of its patented Quicksome™ sublingual delivery platform as part of the Company’s strategy to position Quicksome™ as a differentiated delivery solution within the evolving compounded peptide marketplace across North and South America.

MPOWER Financing, the leading provider of no-cosigner loans for promising international students, has released its 2026 Social Impact Report. The report, which marks 12 years of data-driven insights, highlights the company's role in unlocking global education for over 25,000 students from 183 countries.

NEOS Investments, an asset management firm comprised of leaders and pioneers in the options-based ETF space, announces May monthly distribution amounts for their suite of ETFs that pursue monthly income and tax efficiency across core portfolio exposures.

US Medical Glove Company (USMGC) has reached an impressive milestone in its mission to produce domestically sourced nitrile gloves to help keep Americans safe. Manufactured in Ohio, USMGC’s gloves have been approved for use by Transportation Security Administration (TSA) officers, and they will be procured as a supplier for the Central Association for the Blind and Visually Impaired (CABVI).

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a tumor-only indication for its xT CDx next-generation sequencing platform. With this expanded label, Tempus is the first laboratory to hold FDA companion diagnostic (CDx) approval for both tumor-only and tumor-normal comprehensive genomic profiling.

MidOcean Partners (“MidOcean” or the “Firm”), a premier New York-based alternative asset manager specializing in middle market private equity, alternative credit, and structured equity, announced today the signing of the sale of Bora, Inc. and its subsidiaries (collectively, “Zonda” or the “Company”) to CoStar Group, Inc. (NASDAQ: CSGP) (“CoStar Group”).

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will participate in the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting, taking place May 29 – June 2, 2026 in Cleveland, Ohio. At the meeting, NeuroPace will highlight the expanding role of responsive neuromodulation in epilepsy care, including long-term clinical outcomes with the RNS® System, NAUTILUS results in idiopathic generalized epilepsy (IGE), and the continued evolution of data-driven tools that support treatment planning, patient management and practice development.

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential.

CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, and analytics across the property markets, today announced that it has entered into a definitive agreement to acquire Zonda, a leading provider of new home construction data, homebuilder software, and residential real estate marketplaces, for $800 million in cash.

The 19(a) monthly distribution notices for Putnam Managed Municipal Income Trust (NYSE: PMM) and Putnam Municipal Opportunities Trust (NYSE: PMO) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement. The table below provides an estimate of the sources of the Fund’s current distribution and its cumulative distributions paid this fiscal year-to-date. Amounts are expressed on a per share of common stock basis, and as a percentage of the distribution amount.

Siesta Valley Bowl, the intimate 1,000-person capacity outdoor amphitheater nestled in the Berkeley Hills in Orinda and former home of California Shakespeare Theater, today announced its inaugural season of live music. The venue will open its doors on Friday, June 5th, with a performance by proto-punk legend Jonathan Richman.

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced FDA approval of ECoG Assistant, its first AI-driven clinician-enabled feature. This milestone represents an important step in NeuroPace’s broader AI platform strategy, leveraging the world’s only long-term intracranial EEG dataset to transform how epilepsy is monitored and managed.

REX Shares ("REX") and Tuttle Capital Management ("TCM") today announce the launch of the T-REX 2X Long TE Daily Target ETF (Cboe: TEUP), a leveraged ETF providing 2x daily long exposure to T1 Energy Inc. (NYSE: TE).

Bristol Myers Squibb (NYSE: BMY) today announced positive late-breaking results from the Phase 3 SUCCESSOR-2 trial (NCT05552976) of CELMoD (cereblon E3 ligase modulation) mezigdomide in combination with carfilzomib and dexamethasone (MeziKd) versus carfilzomib and dexamethasone alone (Kd) in patients with relapsed or refractory multiple myeloma (RRMM). Results showed MeziKd demonstrated a clinically meaningful and statistically significant improvement in progression-free survival (PFS) (95% CI: 18 months vs. 8.3 months [HR:0.48; p<0.0001]), representing a 52% reduction in the risk of disease progression or death compared with Kd.

ChargePoint (NYSE: CHPT), a global leader in electric vehicle (EV) charging solutions, and Powers Parts, a national distributor of electric and advanced mobility components, today announced a new partnership to accelerate transit electrification across North America.

Pfizer Inc. (NYSE: PFE) today announced unprecedented seven-year follow-up results from the Phase 3 CROWN trial evaluating LORBRENA® (lorlatinib, a third-generation ALK inhibitor, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).

Raydium, the highest-volume decentralized exchange on Solana and the on-chain liquidity protocol behind more than $1 trillion in cumulative trading volume, has had its RAY token listed on Revolut and Robinhood. The back-to-back listings make RAY the first token from a Solana-based decentralized exchange available on both consumer finance apps.

The Board of Directors of Best Buy Co., Inc. (NYSE:BBY) has authorized the payment of a regular quarterly cash dividend of $0.96 per common share. The quarterly dividend is payable on July 9, 2026, to shareholders of record as of the close of business on June 18, 2026. The company had 210,718,220 shares of common stock issued and outstanding as of May 2, 2026.

Okta, Inc. (Nasdaq: OKTA), the leading independent identity provider, today announced that a member of its management team is scheduled to participate in an upcoming investor conference.

Research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting by The US Oncology Network (The Network), an organization dedicated to advancing cancer care in the community and supported by McKesson, found that new patient consult models in benign hematology led by advanced practice providers (APP) can accelerate access to care and increase capacity across diverse community oncology settings.

Circus SE (ISIN: DE000A2YN355 / XETRA: CA1) today publishes preliminary figures for the financial year ended December 31, 2025.

Piraeus has been recognised for the sixth consecutive year in the FT’s Europe’s Climate Leaders 2026 ranking, compiled by Financial Times and Statista, as one of the 600 leading European companies that are acknowledged for their outstanding performance in reducing greenhouse gas emissions and advancing climate-related commitments.

Yesterday, the American Center for Manufacturing & Innovation (ACMI) broke ground on the Maryland Energetics Innovation Hub (MEIH), a first-of-its-kind defense manufacturing and innovation hub designed to modernize how the United States develops, tests, and scales critical technologies and energetics production for the military.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced the relaunch of the Tweed brand in the German medical market, alongside the introduction of three cannabis strains developed by MTL Cannabis Corp. (“MTL”), a wholly-owned subsidiary of the Company. The dual milestone represents the Company’s first international product release following its recent acquisition of MTL.

UnitedHealthcare is removing two-thirds of authorization requirements for members under age 18 by year’s end. This move is the latest in a series of initiatives to simplify the healthcare system for providers and patients.

PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage company redefining early cancer treatment with therapeutic implants administered directly at the tumor site, today announced that it has concluded the dose escalation portion of its Phase 1b clinical trial of PTM-101 in pancreatic ductal adenocarcinoma (PDAC). PanTher has identified the PTM-101 400mg paclitaxel-containing implant as the recommended Phase 2 dose (RP2D) in combination with neoadjuvant standard of care chemotherapy. In addition, PanTher announced the appointment of senior life sciences executive Dr. Tim Clackson to its Board of Directors. This news reflects a pivotal stage in the company’s development to achieve the promise of the PTM-101 technology.

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR).

Church & Dwight Co., Inc. (NYSE:CHD) has signed and closed a definitive agreement to acquire the fast-growing Miss Mouth’s Messy Eater® brand for approximately $325 million. The brand has gained a rapid following among customers in need of fast-acting, non-toxic, on-the-spot stain removal across multiple surfaces. The transaction closed on May 28th.

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership.

Genesco Inc. (NYSE: GCO) today reported first quarter results for the three months ended May 2, 2026.

The Buckle, Inc. (NYSE: BKE) announced today that net income for the fiscal quarter ended May 2, 2026 was $46.9 million, or $0.93 per share ($0.92 per share on a diluted basis).

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibitor, in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the first-line treatment of patients with advanced or metastatic non-small cell lung cancer (NSCLC) with KRAS G12C-mutation and expressing PD-L1 (tumor proportion score [TPS] ≥1%). This is the first Breakthrough Therapy designation for calderasib and was supported by positive data from the Phase 1 KANDLELIT-001 trial.

Fresha, the world’s leading AI-powered booking platform for beauty and wellness, is further expanding its Marketplace capabilities, introducing a new era of personalization, discovery, and customization features designed to help businesses showcase their identity and services, connect more meaningfully with clients, and convert inspiration directly into bookings.

Natuzzi S.p.A. (NYSE: NTZ) (“Natuzzi” or the “Company”) today announced that Mr. Pietro Labriola has resigned from his position as a member of the board of directors.

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL.